Remestemcel-L (Ryoncil) is an allogeneic bone marrow‒derived mesenchymal stromal cell therapy for steroid-refractory acute graft-vs-host dis...

The determination means that compounding pharmacies will have to stop making cheaper knock-off versions.

The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli Lilly’s (LLY) popular...

The recent recall of limited batches of Lay's potato chips due to undeclared allergens underscores the vital importance of food safety and t...

Ustekinumab-stba, manufactured by Celltrion, is expected to be marketed in the United States in February 2025. Medscape Medical News

The FDA has issued a Class I Recall for dog treats sold by Carolina Prime Pet

The FDA has issued a Class I Recall for dog treats sold by Carolina Prime Pet

SILVER SPRING, Md., Dec. 18, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an all...

The next-generation ALK-inhibitor more than doubled progression-free survival compared with crizotinib. Medscape Medical News

Elsevier issued its formal retraction on Tuesday. Read More

STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well...

The FDA's top food official says the safety of the dye called Red 40 hasn't been assessed in over a decade, despite concerns over its potent...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was approximately 80 consecutiv...

Aaron Siri is interviewing and helping choose candidates for high-level health roles, according to the New York Times. Read More

- Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerreshei...